ArticleJournal of physiology and biochemistry2013
Changes in serum parameters associated with iron metabolism in male rat exposed to lead.
Article in Journal of physiology and biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02743572 (Efficacy and Safety of Parenteral Nutrition With Iron Sucrose for Anemia in Preterm Infants), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Safety of Parenteral Nutrition With Iron Sucrose for Anemia in Preterm Infants: a Randomized, Double-blind Controlled Study
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- The Effect of a Short-Term Exposure to Lead on the Levels of Essential Metal Ions, Selected Proteins Related to Them, and Oxidative Stress Parameters in Humans.Oxidative medicine and cellular longevity · 2017Trial
- Innovative Plant-Based Nutraceuticals: Enhancing Iron Bioavailability to Address Iron Deficiency Anaemia.Antioxidants (Basel, Switzerland) · 2025Article
- Iron, hepcidin, and the metal connection.Frontiers in pharmacology · 2014Review
- Protective effects of copper against aluminum toxicity on acetylcholinesterase and catecholamine contents of different regions of rat's brain.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the severe hazardous influences of lead (Pb(2+)) on iron-related diseases, the effects of Pb(2+) on serum parameters associated with iron metabolism have been studied in this project. Male Wistar rats weighing 200-250 g were treated with Pb(2+) for the short and long period of times. The animals received daily intraperitoneal injection of 100 mg Pb(2+) kg(-1) body weight (BW) for 5 days and 4 mg kg(-1) BW of Pb(2+) for 30 and 45 days, respectively. The results show that when animals were treated with both low and high concentrations of Pb(2+), serum iron concentration decreased markedly, by 23.2, 32.8, and 39.9 %, while the sera TIBC and transferrin concentrations increased significantly (p < 0.05). Following short- and long-term exposures to Pb(2+), the percentage of serum transferrin saturation was also decreased in comparison with the untreated control group (p < 0.05). Concentrations of serum copper and ceruloplasmin following Pb(2+) treatments also reduced significantly (p < 0.05). The percentage of hematocrit and hemoglobin levels was reduced (p < 0.05) in all Pb(2+)-treated animals in comparison with the controls. These results suggest that Pb(2+) changes the serum parameters related to iron metabolism, which may play an important role in producing iron-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.